After the evaluation of data, Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Bharat Biotech, the manufacturer of Covaxin, has submitted data for clinical trials in the age group of 2-18 years to Central Drugs Standard Control Organisation (CDSCO).
The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and has provided their positive recommendations. (ANI)
